Tomas Jernberg

Showing 1-2 of 2 articles

Coronary interventions

Intravenous beta-blocker therapy in ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention is not associated with benefit regarding short-term mortality: a Swedish nationwide observational study

Mohammad M, Andell P, Koul S, Desta L, Jernberg T, Omerovic E, Spaak J, Fröbert O, Jensen J, Engstrøm T, Hofman-Bang C, Persson H, Erlinge D

June 2, 2017 | 10.4244/EIJ-D-16-01021

Coronary interventions

Invasive strategies and outcomes for non-ST-segment elevation acute coronary syndromes: a twelve-year experience from SWEDEHEART

Damman P, Jernberg T, Lindahl B, de Winter R, Jeppsson A, Johanson P, Held C, James S

October 20, 2016 | 10.4244/EIJY15M11_05

1

Latest news

LM revascularisation, annulus rupture, risk stratification, renal denervation

Ahead of print: Transcatheter treatment of multivalvular heart disease

Cardioband after placement of 17 screws before and after

Balancing risks and benefits of LM revascularisation strategies in CKD patients

Gennaro Giustino

Last Update: CULPRIT, NOBEL, IVUS-XPL, SAFARI-STEMI

(supported by Biotronik)

Guidance Papers

Guidelines, consensus & position papers

Contained annulus ruptures – the price to pay for optimal haemodynamic results?

Fabian Nietlispach

This week's JAA's: Right pulmonary artery to left atrium fistula, BRS in high-risk patients

Coronary

Valvular disease

Heart failure

Peripheral

Hypertension

Stroke